NDC 67877-730-32 - Roflumilast
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67877-730
- Requested NDC
- 67877-730-32
- Package NDCs from labels
- 67877-730-30, 67877-730-90, 67877-730-05, 67877-730-32, 67877-730-93, 67877-730-87
- Manufacturer
- Ascend Laboratories, LLC | Alkem Laboratories Limited
- Effective date
- 2025-03-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Roflumilast - Ascend Laboratories, LLC | Alkem Laboratories Limited | Ascend Laboratories, LLC | Alkem Laboratories Limited | 2025-03-13 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67877-730-05 | Roflumilast | 500 in 1 BOTTLE | TABLET | 500 | 5 | |
| 67877-730-30 | Roflumilast | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 67877-730-32 | Roflumilast | 7 in 1 BLISTER PACK | TABLET | 7 | 5 | |
| 67877-730-87 | Roflumilast | 28 in 1 BLISTER PACK | TABLET | 28 | 5 | |
| 67877-730-87 | Roflumilast | 1 in 1 CARTON | TABLET | 1 | 5 | |
| 67877-730-90 | Roflumilast | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 67877-730-93 | Roflumilast | 4 in 1 CARTON | TABLET | 4 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67877-730-32 | EA - Each | 67877-730 | 0c341040-18f7-49f2-8df7-bc7005e750e7 | 1 | 2025-05-14 |
| 67877-730-93 | EA - Each | 67877-730 | cb7cdecf-3883-4456-a05d-3f8c6f9828c7 | 1 | 2025-05-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Roflumilast | ROFLUMILAST | Camber Pharmaceuticals, Inc. | f25a0230-3cf6-4366-bebe-0ea5ff8de5ab | 2023-04-28 | Warnings, Adverse reactions | 2001319 1091839 0P6C6ZOP5U |
| ROFLUMILAST | ROFLUMILAST | Solco Healthcare US, LLC. | 4251c764-7224-4f94-9de7-b6c76cb1f5cd | 2022-05-10 | Warnings, Adverse reactions | 1091839 0P6C6ZOP5U |
| Daliresp | ROFLUMILAST | AstraZeneca Pharmaceuticals LP | c9a1d0a8-581f-4f91-a2b8-f419192d0ebf | 2020-03-12 | Warnings, Adverse reactions | 2001319 1091839 0P6C6ZOP5U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.